3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
80
Colonic Neoplasms
18
Neoplasm Metastasis
17
Rectal Neoplasms
14
Neoplasms
13
Stomach Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Lung Neoplasms
4
Gastrointestinal Neoplasms
4
Carcinoma, Renal Cell
3
Carcinoma, Neuroendocrine
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Brain Neoplasms
2
Adenocarcinoma
2
Urinary Bladder Neoplasms
1
Unresectable Metastatic Colorectal Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ras-mutated Metastatic Colorectal Cancer
1
Prostatic Neoplasms
1
Interventions
Microscopy, Confocal
2
Indocyanine Green
2
Everolimus
2
varlilumab
1
Ultrasonography
1
Sunitinib
1
Simvastatin
1
Radiosurgery
1
Palliative Care
1
Neoadjuvant Therapy
1
Narrow Band Imaging
1
Interferon alpha-2
1
IFL protocol
1
Gastrectomy
1
Folfox protocol
1
Endoscopic Mucosal Resection
1
Drug Delivery Systems
1
Drug Combinations
1
Dermoscopy
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Margins of Excision
×
IFL protocol
×
Clear all
NCT04389086
2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3
Recruiting
364 enrolled